Journal of neuro-oncology

Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Journal of neuro-oncology

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA

Erratum to: Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Journal of neuro-oncology

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA

The role of emerging therapy in the management of patients with diffuse low grade glioma.

Journal of neuro-oncology

Sloan AE, Okada H, Ryken TC, Kalkanis SN, Olson JJ

The role of emerging therapy in the management of patients with diffuse low grade glioma.

Journal of neuro-oncology

Sloan AE, Okada H, Ryken TC, Kalkanis SN, Olson JJ

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Journal of neuro-oncology

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, James CD, Mueller S, Haas-Kogan DA

Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma.

Journal of neuro-oncology

Dasgupta T, Olow AK, Yang X, Hashizume R, Nicolaides TP, Tom M, Aoki Y, Berger MS, Weiss WA, Stalpers LJ, Prados M, David James C, Mueller S, Haas-Kogan DA

Pages